IBIO vs SRZN
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 13, 2026
IBIO
SRZN
Investment Advisor Scores
SRZN
AI Analyst Insights
Detailed Metrics Comparison
| Metric | IBIO | SRZN | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 0 | Tie |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -100.0% | 408.6% | SRZN |
| Earnings Growth | 0.0% | -37.0% | IBIO |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 36.7/100 | 29.7/100 | IBIO |
| Profit Margin | 0.0% | 0.0% | Tie |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | AVOID NEW MONEY | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
IBIO
MarkdownPrice below a falling SMA50 (slope -20.3%), weak momentum, RSI 41
SRZN
MarkupPrice above SMA50, rising 50-day trend (8.5% over 20 days), RSI 60
Fundamentals Snapshot
| Metric | IBIO | SRZN |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -2.5 | -6.7 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -1.0% | 4.1% |
| Gross Margin | 1.0% | -2.6% |
| Operating Margin | -301.4% | -4.9% |
| EPS | -0.27 | -41.94 |
| Dividend Yield | — | — |